Skip to main content

Advertisement

Table 1 Patients and disease characteristics (n=48)

From: The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

Age (year)  
 32–80 (median 66)
Gender  
 Male 40
 Female 8
Histology  
 Clear cell 41
 Papillary 5
 HD* 1
 Clear/sarcomatoid 1
MSKCC classification  
 Favorable 17
 Intermediate 24
 Poor 7
Nephrectomy  
 Yes 38
 No 10
Prior systematic treatment  
 Non 30
 Cytokine 14
 TKI 4
Evaluated RCC lesions (total 190)
 Lung 49
 Bone 40
 Lymph node 37
 Abdominal organ 29
 Muscle/Soft tissue 26
 Primary 9
  1. HD*: mixed clear cell and papillary renal carcinoma in a hemodialysis patient.